Active
A Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse Following Prior Treatment with Gemcitabine-Containing Therapy
Type of Sarcoma:
Metastatic Leiomyosarcoma
Drug:
Mocetinostat & Gemcitabine
Accrual Status:
Open, Not Accruing
Overall Study Principal Investigator:
Shreyas Patel, MD
Co-Principal Investigator
MD Anderson Cancer Center
Edwin Choy, MD, PhD
Co-Principal Investigator
MGH, Dana Farber/Harvard Cancer Center
Division of Hematology Oncology
Co-Principal Investigator
MD Anderson Cancer Center
Edwin Choy, MD, PhD
Co-Principal Investigator
MGH, Dana Farber/Harvard Cancer Center
Division of Hematology Oncology